BioNTech SE
$58.409876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$58.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$3.60 (-5.81%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell BioNTech SE and other stocks, options, ETFs, and crypto commission-free!
About BNTX
BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. Read More It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders. The company was founded by Christopher Huber, Özlem Türeci and Ugur Sahin in 2008 and is headquartered in Mainz, Germany.
CEO
Employees
1,032
Headquarters
Mainz, Rheinland-Pfalz
Founded
2008
Market Cap
12.47B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.39M
High Today
$62.00
Low Today
$57.00
Open Price
$59.86
Volume
240.12K
52 Week High
$105.00
52 Week Low
$12.53
Collections
Analyst Ratings
38%
of 8 ratings
Buy
38%
Hold
63%
Sell
0%
BNTX Earnings
-$0.28
-$0.19
-$0.09
$0.00
Q3 2019
Q4 2019
Estimated
-$0.14 per share
Actual
-$0.28 per share